Susana Ecenarro Probst
Vice-President R&D & Regulatory, Qualicaps EMEA & South Asia

Is this your profile?

About

Susana Ecenarro is Vice-President of R&D and Regulatory Affairs for Qualicaps EMEA and South Asia. She holds an MBA, Green Belt Six Sigma certification and a bachelor’s degree in pharmacy. Her professional career started in the German pharma company Schering AG where, for almost 20 years, she led different quality teams with several responsibilities, including validations and technology transfers, US FDA audits, GMPs, analytical development, operational excellence projects, etc.

Before joining Qualicaps, Ms Ecenarro was responsible for the Analytical Development R&D unit at the Bayer Healthcare facility in Spain for five years. The R&D department established within the Qualicaps EMEA company enforces innovative new capsule product launches through new product development, industrial scaling up and a customer added-value services centre. The aim is to strengthen the customer-specific Rx and Gx capsule projects with the company’s capabilities for the customisation of the capsules and with yearly academia/third-party collaborations linked to important, valuable scientific content generation.

Contributions

CHALLENGES AND ACHIEVEMENTS OF TIO₂ REPLACEMENT IN HARD CAPSULES

Susana Ecenarro Probst looks at the issues arising in replacing TiO₂ in hard capsules and introduces Qualicaps' alternative hard capsule formulation.

More contributions

CHARACTERISING WALL THICKNESS OF QUALI-V^®-I CAPSULES & ITS EFFECT ON CAPSULE PUNCTURE BY A DPI PIN

Siamac Parker, Sion Coulman, Prof James Birchall alongside Susana Ecenarro and Mahmoud Farag, present a study that uses optical coherence tomography to characterise the wall thickness of capsules at the dome position and investigates the importance of controlling the dome thickness of hard-shell capsules to be used in a dry powder inhaler.

EVALUATING THE MECHANICAL PROPERTIES OF “EXTRA DRY” HARD-SHELL CAPSULES

Sion Coulman, Siamac Parker, Prof James Birchall, Susana Ecenarro and Mahmoud Farag discuss new developments in low moisture content capsule technology for hygroscopic and very moisture-labile APIs.

INDUSTRIALISATION

QUALI-V EXTRA DRY: A NOVEL CAPSULE FOR DELIVERING HYGROSCOPIC FORMULATIONS

Jose Luis Encinas and Susana Ecenarro explore how the use of Quali-V^® Extra Dry capsules can help improve product stability and, crucially, lead to efficiencies and savings in drug product manufacture.

INHALABLE THERAPEUTIC BIOLOGICS, A PARADIGM SHIFT FOR NON-INVASIVE EFFICIENT MEDICAL TREATMENTS

Susana Ecenarro Probst and Francesca Buttini discuss the rising prominence of biologics in the pharmaceuticals market and how dry powder inhalers utilising hard capsules are a promising potential delivery method for these new drugs.

AN OVERVIEW OF DRY POWDER INHALATION FOR SYSTEMIC DRUG DELIVERY

Brian Jones and Susana Ecenarro Probst discuss the growing interest in using inhaled APIs to treat systemic conditions. Furthermore, they review some of the methods used to engineer molecules to be suitable for DPI capsules and look to the possibility of administering biomolecules via the pulmonary route.

AN ENVIRONMENTALLY FRIENDLY & EFFICIENT DOSAGE FORM

Susana Ecenarro Probst presents evidence, set against the backdrop of environmental concerns over HFC propellants in MDIs, supporting the adoption of dry-powder inhalers as an attractive alternative.

Top